OptimizeRx Corporation (OPRX)
NASDAQ:OPRX
US Market
Holding OPRX?
Track your performance easily

OptimizeRx (OPRX) Financial Statements

453 Followers

OptimizeRx Financial Overview

OptimizeRx's market cap is currently ―. The company's EPS TTM is $-0.999; its P/E ratio is -7.68; OptimizeRx is scheduled to report earnings on November 5, 2024, and the estimated EPS forecast is $0.06. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 18.81M$ 19.69M$ 28.37M$ 16.33M$ 13.82M
Gross Profit$ 11.70M$ 12.20M$ 17.84M$ 9.80M$ 13.82M
EBIT$ -5.10M$ -5.01M$ -8.11M$ -2.87M$ -4.16M
EBITDA$ -3.84M$ -3.76M$ -6.89M$ -2.40M$ -3.70M
Net Income Common Stockholders$ -4.01M$ -6.90M$ -4.14M$ -2.87M$ -4.16M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 0.00$ 0.00$ 13.85M$ 53.62M$ 62.74M
Total Assets$ 172.88M$ 176.37M$ 183.37M$ 123.93M$ 121.32M
Total Debt$ 36.09M$ 36.46M$ 36.82M$ 148.64K$ 14.54K
Net Debt$ 36.09M$ 36.46M$ 22.97M$ -53.47M$ -62.73M
Total Liabilities$ 51.86M$ 53.83M$ 56.82M$ 7.82M$ 5.51M
Stockholders Equity$ 121.02M$ 122.54M$ 126.55M$ 116.11M$ 115.82M
Cash Flow-
Free Cash Flow$ 737.00K$ 2.09M$ -6.25M$ 1.44M$ -2.39M
Operating Cash Flow$ 782.00K$ 2.12M$ -6.26M$ 1.47M$ -2.37M
Investing Cash Flow$ -85.00K$ -153.00K$ -26.00M$ -1.01M$ 3.22M
Financing Cash Flow$ -915.00K$ -640.00K$ 36.19M$ -349.43K$ -7.49M
Currency in USD

OptimizeRx Earnings and Revenue History

OptimizeRx Debt to Assets

OptimizeRx Cash Flow

OptimizeRx Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis